Chen Chao, Si Tian-Mei, Xiang Yu-Tao, Ungvari Gabor S, Wang Chuan-Yue, He Yan-Ling, Kua Ee-Heok, Fujii Senta, Sim Kang, Trivedi Jitendra K, Chung Eun-Kee, Udomratn Pichet, Chee Kok-Yoon, Sartorius Norman, Tan Chay-Hoon, Shinfuku Naotaka
Key Laboratory of Mental Health, Ministry of Mental Health and Peking University Institute of Mental Health, Beijing 100083, China.
Chin Med J (Engl). 2015 Apr 5;128(7):853-8. doi: 10.4103/0366-6999.154272.
Depression is often comorbid with chronic somatic diseases. Few previous studies have investigated the prevalence of somatic diseases in depression or the prescription pattern of antidepressants in comorbidly depressed patients in Asia. This study aimed to investigate the prevalence of somatic comorbidity (SC) in depression and compared the prescriptions of antidepressants in depressed patients with and without SC.
A total of 2320 patients treated with antidepressants in 8 Asian countries were examined, and a diagnosis was based on the International Classification of Disease, 10 th revision. We listed 17 common chronic somatic diseases. Patients' socio-demographic and clinical characteristics and psychotropic drug prescriptions were recorded using a standardized protocol and data collection procedure.
Of the patients examined, 1240 were diagnosed with depression and 30% of them (n = 375) had SC. The most common comorbid condition was diabetes (23.7%). The patients with SC were more likely to seek help at a general hospital (74.7% vs. 47.2%), and had a higher incidence of symptoms involving sadness, disturbed sleep, and poor appetite. Noradrenergic and specific serotonergic antidepressant was prescribed more for patients with SC than for those without SC (30.4% vs. 22.9%).
SC is common in depressed Asian patients. It is important to strengthen the recognition of depression, especially in general hospitals and when patients report some somatic discomfort. It is also a matter of urgency to establish evidence-based guidelines for the use of new antidepressants in depressed patients with SC.
抑郁症常与慢性躯体疾病共病。此前很少有研究调查亚洲抑郁症患者中躯体疾病的患病率或共病抑郁症患者的抗抑郁药处方模式。本研究旨在调查抑郁症患者中躯体共病(SC)的患病率,并比较有和没有SC的抑郁症患者的抗抑郁药处方。
对8个亚洲国家的2320例接受抗抑郁药治疗的患者进行了检查,并根据《国际疾病分类》第10版进行诊断。我们列出了17种常见的慢性躯体疾病。使用标准化方案和数据收集程序记录患者的社会人口统计学和临床特征以及精神药物处方。
在接受检查的患者中,1240例被诊断为抑郁症,其中30%(n = 375)患有SC。最常见的共病情况是糖尿病(23.7%)。患有SC的患者更有可能在综合医院寻求帮助(74.7%对47.2%),并且出现悲伤、睡眠障碍和食欲不振等症状的发生率更高。与没有SC的患者相比,患有SC的患者使用去甲肾上腺素能和特异性5-羟色胺能抗抑郁药的比例更高(30.4%对22.9%)。
SC在亚洲抑郁症患者中很常见。加强对抑郁症的认识很重要,尤其是在综合医院以及患者报告一些躯体不适时。为患有SC的抑郁症患者制定基于证据的新型抗抑郁药使用指南也迫在眉睫。